U.S. FDA approves laser phototherapy device for hair restoration in men

April 9, 2018

Theradome has received U.S. FDA clearance to market its LH80 PRO laser phototherapy hair restoration device to men.

Theradome's LH80 PRO Laser Helmet, which uses laser phototherapy to stimulate hair growth, is now U.S. FDA-approved for use by men.

Medical device maker Theradome (Pleasanton, CA) has received U.S. FDA clearance to market its LH80 PRO laser phototherapy hair restoration device to men.

Previously only available to women, the LH80 PRO Laser Helmet leverages laser phototherapy (also known as low-level laser light therapy) to stimulate weak hair follicles and provide them with targeted laser energy, which improves cellular metabolism and protein synthesis required to grow and maintain a healthy head of hair.

The device, which produces results with two 20-minute treatments each week, uses 80 red lasers to generate over 440 J of energy and treat the full scalp area. The lasers delivers the optimum wavelength of light for hair growth (678 nm).

For more information, please visit www.theradome.com.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)